RESEARCH & DEVELOPMENT (PRECLINICAL LAB APIs)
CLINICAL PHASE API SUPPLIES
COMMERCIAL STAGE CGMP APIs
APIs FOR DRUG DELIVERY SYSTEMS
REGULATORY SUPPORT SERVICES
CONTRACT RESEARCH & MANUFACTURING SERVICES
OUR 505(b)(2) EXPERTISE
WHAT IS A 505(b)(2) FILING?
PRESS & MEDIA
Search products by name or CAS#
LGM Pharma is a Buformin CAS# 692-13-7 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
Questions? Call our customer API support number 1-(800)-881-8210.
LGM Pharma offers this active ingredient but not the finished dosage forms.
Inquire about this product >>
: Compound 2468
: 1-Butylbiguanide, 1-Butyldiguanide, 4-04-00-00582 (Beilstein Handbook Reference), BRN 0607037, Buformin, Buformina, Buformina [INN-Spanish], Buformine, Buformine [INN-French], Buforminum, Buforminum [INN-Latin], Butformin, Butylbiguanide, Butylbiguanidum, Butyldiguanide, DBV, EINECS 211-726-4, Glybigid, Glybigidum, H 224, N-Butylbiguanide, UNII-W2115E9C7B, W 37
Verdonck LF, Sangster B, van Heijst AN, de Groot G, Maes RA: Buformin concentrations in a case of fatal lactic acidosis. Diabetologia. 1981;20(1):45-6.
Deppermann D, Heidland A, Ritz E, Horl W: [Lactic acidosis—a possible complication in buformin-treated diabetics (author’s transl)] Klin Wochenschr. 1978 Sep 1;56(17):843-53.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
API’s From Quality Manufacturers:
Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF,
ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any
submission type based on specific customer requirements